Skip to content
← Back to this collection

PUBLICATIONS · 28471719

Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2017 Aug 1
First author
Park JR

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Park JR
      type
      Author
    2. name
      Bagatell R
      type
      Author
    3. name
      Cohn SL
      type
      Author
    4. name
      Pearson AD
      type
      Author
    5. name
      Villablanca JG
      type
      Author
    6. name
      Berthold F
      type
      Author
    7. name
      Burchill S
      type
      Author
    8. name
      Boubaker A
      type
      Author
    9. name
      McHugh K
      type
      Author
    10. name
      Nuchtern JG
      type
      Author
    11. name
      London WB
      type
      Author
    12. name
      Seibel NL
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Park JR
      type
      Author
    2. name
      Bagatell R
      type
      Author
    3. name
      Cohn SL
      type
      Author
    4. name
      Pearson AD
      type
      Author
    5. name
      Villablanca JG
      type
      Author
    6. name
      Berthold F
      type
      Author
    7. name
      Burchill S
      type
      Author
    8. name
      Boubaker A
      type
      Author
    9. name
      McHugh K
      type
      Author
    10. name
      Nuchtern JG
      type
      Author
    11. name
      London WB
      type
      Author
    12. name
      Seibel NL
      type
      Author
    bibliography ids
    1. nci-bib-b4ea7bb5a77e50e82b66ffcf
    book metadata
    content sha256
    631cb7a39cfa3fae92edb191cb2192c5bc2fa996d358b34e9a4c19277357e4df
    document type
    citation
    dois
    1. 10.1200/JCO.2016.72.0177
    electronic publication date
    display
    2017 May 4
    precision
    day
    year
    2017
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:28471719
    immutable id
    pubmed:28471719@631cb7a39cfa3fae92edb191cb2192c5bc2fa996d358b34e9a4c19277357e4df
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    22
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    2580-2587
    volume
    35
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      28471719
      provenance
      batch id
      1c173f0e18be0c6d461b
      provider
      NCBI PubMed ESummary
      record sha256
      c1f67be6e7ccf72867d1d0577bacb6fdd524bb80d15c1d7cfae3e4bbefc93cec
      response sha256
      27a6f8bb5d49a8d376b07e1b1768913c558986bf73de92cdd65c8f05a5fa1e61
      retrieved at
      2026-09-09T23:47:25.975513+00:00
      publication date
      display
      2017 Aug 1
      precision
      day
      year
      2017
      publication types
      1. Consensus Development Conference, NIH
      2. Journal Article
      3. Review
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/28471719/
      title
      Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.

      Preserved source evidence · Not medical advice